The Union government is evaluating wide‑ranging reforms in the health‑insurance sector, including benchmarked treatment rates and the creation of a national claims exchange, as policymakers seek to rein in one of Asia’s fastest medical inflation rates, Reuters reported on Wednesday.
Policy push driven by persistent medical cost rise
According to two people familiar with the discussions, medical inflation in India is running at roughly 12–14 percent annually, a level that erodes household budgets and is prompting regulators to explore measures for greater pricing clarity and uniformity. The proposals are under review by a panel comprising regulators, insurers, hospital representatives and industry bodies, which is expected to put forward recommendations by year‑end.
The panel is chaired by the Insurance Regulatory and Development Authority of India (IRDAI), the people said. Implementation of any agreed reforms would follow the submission of the report, the sources added. IRDAI did not respond to requests for comment, Reuters reported.
Reforms under consideration
Officials and industry insiders described several instruments under study to reduce cost escalation and improve trust in claims processes. Measures reported to be on the table include:
- Benchmarked treatment tariffs to standardise charges across common procedures;
- A national claims exchange to streamline and validate claims data and improve interoperability among insurers, hospitals and third‑party administrators;
- Clearer billing and coverage rules aimed at reducing unwarranted or fraudulent claims.
Industry estimates cited in reporting place unwarranted or fraudulent claims at around 10–15 percent of claims, a figure that regulators say undermines premium affordability and sectoral trust.
Market context and pressures
India’s health‑insurance market has been expanding as authorities seek to raise coverage across the population of about 1.4 billion. Nevertheless, insurance spending remains proportionally low: it stands at under 4 percent of GDP, versus a global average above 7 percent, according to the report.
The broader insurance sector has been opened to greater foreign capital and altered distribution rules in recent years to encourage expansion. The market is large: Reuters cited a figure of roughly $130 billion for the insurance market and reported health insurance premiums at about ₹1.17 trillion (approx. $12.3 billion) for the year ended March 2025.
Parliamentary concern about private healthcare affordability has been mounting. A committee report referenced in the coverage noted that average stays in private hospitals cost about $530, compared with about $70 at public facilities — a disparity that has contributed to calls for regulatory action.
| Indicator | Reported value |
|---|---|
| Medical inflation | 12–14 % annually |
| Estimated unwarranted/fraudulent claims | 10–15 % |
| Health insurance premiums (FY 2024–25) | ₹1.17 trillion (~$12.3 bn) |
| Insurance spend as % of GDP | Below 4 % (vs global >7 %) |
Implications for patients and providers
Experts and industry participants quoted in reporting suggested that establishing standardised tariffs and clearer billing norms could be among the most effective levers to temper cost growth over time. Such measures aim to provide greater pricing transparency for consumers, reduce disputes between hospitals and payers, and limit opportunities for inflated or inappropriate billing.
However, stakeholders caution that implementation details will be crucial. A national claims exchange, if designed with robust governance and data privacy safeguards, could improve fraud detection and speed up claim settlements; poorly crafted systems, by contrast, might add administrative burdens or lead to unintended cost shifts.
Lawmakers have urged swift action to make private healthcare more affordable as consumer costs continue to rise. The panel’s recommendations, expected by the end of the year, will be closely watched by insurers, hospital chains, trade bodies and patient groups.
Readers are reminded that this report is based on published coverage of ongoing policy discussions. For personal medical or insurance advice, consult a qualified doctor or licensed insurance professional.
